MISUSE OF DRUGS ACT
With effect from 1 May 2016, the Central Narcotics Bureau (CNB) will be listing all 20 New Psychoactive Substances (NPS) and one tryptamine generic group currently in the Fifth Schedule of the Misuse of Drugs Act (MDA), in
the First Schedule of the same Act. This means that these substances will bereclassified as Class A controlled drugs (see Annex A for the list of drugs). Two new psychoactive substances commonly known as MT-45 and 4,4’-DMAR will also be listed in
the First Schedule as a Class A controlled drug (see Annex B).
Global NPS Situation
CENTRAL NARCOTICS BUREAU
29 APRIL 2016
 New psychoactive substances (NPS) refer to substances which produce the same (or similar) effects as controlled drugs such as cannabis, cocaine, “ecstasy”, methamphetamine or heroin.
 UNODC EWA: 75 NPS reported for the first time in 2015. Retrieved on 28 April 2016 from https://www.unodc.org/LSS/Announcement/Details/fabc16bf-b290-4ea1-a61c-feaea71f692d